BioSapien raised $5.5M in a pre-Series funding round led by Global Ventures to accelerate clinical trials and product development.
Amount Raised
$5.5 Million
Round Type
Series A
Investors
Description
BioSapien has successfully secured $5.5 million in a pre-Series funding round led by Global Ventures. The funds will be used to support clinical trials in the UAE and enhance product development and manufacturing.
Quick answer
BioSapien raised $5.5 Million in a Series A round, dated December 13, 2024. Investors: Dara Holdings and Global Ventures.
- How much did BioSapien raise?
- BioSapien raised $5.5 Million in a Series A round on December 13, 2024.
- Who invested in BioSapien?
- Dara Holdings and Global Ventures are named as investors in this round.
- What does BioSapien do?
- Biosapien is a late-stage pre clinical company focused on novel drug delivery platforms.
- Who are the decision-makers at BioSapien?
- Fundz holds 1 contact at BioSapien. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as BioSapien that raised within 45 days of this round, from Fundz verified event records.
- NRx Pharmaceuticals raised $3.5M (Seed) on January 27, 2025.
- Lipella Pharmaceuticals raised $2.6M (Seed) on December 23, 2024.
- Qnovia raised $14M on October 29, 2024.
- Neumirna Therapeutics raised $20M (Series A) on January 13, 2025.
- First Ascent Biomedical raised $6M (Angel) on January 13, 2025.
- Windward Bio raised $200M (Series A) on January 10, 2025.
Who to call at BioSapien, and when
A new round usually means BioSapien is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BioSapien raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioSapien, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioSapien. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioSapien raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBioSapien raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.